TY - JOUR
T1 - RGD density along with substrate stiffness regulate hPSC hepatocyte functionality through YAP signalling
AU - Gentleman, Eileen
AU - Rashid, Tamir
AU - Blackford, Samuel
AU - Jowett, Geraldine
AU - Yan, Ziqian
AU - Yu, Tracy
AU - Norman, Michael
AU - Guo, Yunzhe
AU - Syanda, Adam
AU - Riccio, Federica
AU - Ng, Soon Seng
AU - Manolakakis, Michail
AU - Lachowski, Dariusz
AU - Garrita, Elena
AU - Vernia, Santiago
AU - de Rio Hernandez, Armando
N1 - Funding Information:
Guy's and St Thomas' NHS Foundation Trust Biomedical Research Centre (GSTT BRC) Ph.D. award: SJIB.This research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London and/or the NIHR Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. We acknowledge Cell and Gene Therapy Catapult (London, UK) and Dr. Ricardo Baptista for the generation and provision of the CGT‐RCiB‐10 hiPSC line. LiPSC‐GR1.1 was supported by the NIH Common Fund Regenerative Medicine Generation of the GMP Program, and reported in Stem Cell Reports. The NIH Common Fund and the National Center for Advancing Translational Sciences (NCATS) are joint stewards of the LiPSC-GR1.1 resource.
Funding Information:
We acknowledge Cell and Gene Therapy Catapult (London, UK) and Dr. Ricardo Baptista for the generation and provision of the CGT‐RCiB‐10 hiPSC line. LiPSC‐GR1.1 was supported by the NIH Common Fund Regenerative Medicine Generation of the GMP Program, and reported in Stem Cell Reports. The NIH Common Fund and the National Center for Advancing Translational Sciences ( NCATS ) are joint stewards of the LiPSC-GR1.1 resource.
Publisher Copyright:
© 2022 The Authors
PY - 2023/1/12
Y1 - 2023/1/12
N2 - Human pluripotent stem cell-derived hepatocytes (hPSC-Heps) may be suitable for treating liver diseases, but differentiation protocols often fail to yield adult-like cells. We hypothesised that replicating healthy liver niche biochemical and biophysical cues would produce hepatocytes with desired metabolic functionality. Using 2D synthetic hydrogels which independently control mechanical properties and biochemical cues, we found that culturing hPSC-Heps on surfaces matching the stiffness of fibrotic liver tissue upregulated expression of genes for RGD-binding integrins, and increased expression of YAP/TAZ and their transcriptional targets. Alternatively, culture on soft, healthy liver-like substrates drove increases in cytochrome p450 activity and ureagenesis. Knockdown of ITGB1 or reducing RGD-motif-containing peptide concentration in stiff hydrogels reduced YAP activity and improved metabolic functionality; however, on soft substrates, reducing RGD concentration had the opposite effect. Furthermore, targeting YAP activity with verteporfin or forskolin increased cytochrome p450 activity, with forskolin dramatically enhancing urea synthesis. hPSC-Heps could also be successfully encapsulated within RGD peptide-containing hydrogels without negatively impacting hepatic functionality, and compared to 2D cultures, 3D cultured hPSC-Heps secreted significantly less fetal liver-associated alpha-fetoprotein, suggesting furthered differentiation. Our platform overcomes technical hurdles in replicating the liver niche, and allowed us to identify a role for YAP/TAZ-mediated mechanosensing in hPSC-Hep differentiation.
AB - Human pluripotent stem cell-derived hepatocytes (hPSC-Heps) may be suitable for treating liver diseases, but differentiation protocols often fail to yield adult-like cells. We hypothesised that replicating healthy liver niche biochemical and biophysical cues would produce hepatocytes with desired metabolic functionality. Using 2D synthetic hydrogels which independently control mechanical properties and biochemical cues, we found that culturing hPSC-Heps on surfaces matching the stiffness of fibrotic liver tissue upregulated expression of genes for RGD-binding integrins, and increased expression of YAP/TAZ and their transcriptional targets. Alternatively, culture on soft, healthy liver-like substrates drove increases in cytochrome p450 activity and ureagenesis. Knockdown of ITGB1 or reducing RGD-motif-containing peptide concentration in stiff hydrogels reduced YAP activity and improved metabolic functionality; however, on soft substrates, reducing RGD concentration had the opposite effect. Furthermore, targeting YAP activity with verteporfin or forskolin increased cytochrome p450 activity, with forskolin dramatically enhancing urea synthesis. hPSC-Heps could also be successfully encapsulated within RGD peptide-containing hydrogels without negatively impacting hepatic functionality, and compared to 2D cultures, 3D cultured hPSC-Heps secreted significantly less fetal liver-associated alpha-fetoprotein, suggesting furthered differentiation. Our platform overcomes technical hurdles in replicating the liver niche, and allowed us to identify a role for YAP/TAZ-mediated mechanosensing in hPSC-Hep differentiation.
UR - http://www.scopus.com/inward/record.url?scp=85146217889&partnerID=8YFLogxK
U2 - 10.1016/j.biomaterials.2022.121982
DO - 10.1016/j.biomaterials.2022.121982
M3 - Article
SN - 0142-9612
VL - 293
JO - Biomaterials
JF - Biomaterials
M1 - 121982
ER -